Point72 Hong Kong’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,733
Closed -$58K 1391
2022
Q3
$58K Buy
+9,733
New +$70.2K ﹤0.01% 1390
2022
Q1
Sell
-480
Closed -$7K 2268
2021
Q4
$7K Buy
+480
New +$9.25K ﹤0.01% 1699

Other funds holding SANA

Point72 Hong Kong's SANA Position: Q4 2022 in Review

Point72 Hong Kong sold out of Sana Biotechnology (SANA) in Q4 2022, closing a stake of 9,733 shares — an estimated $58K sold.

Point72 Hong Kong first reported a position in SANA in Q4 2021 and held it in 2 quarters. The position peaked at $58K in Q3 2022. 119 funds tracked by Wall St. Rank hold SANA as of Q4 2022.

  • Point72 Hong Kong reported no remaining Sana Biotechnology position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 9,733 Sana Biotechnology shares in Q4 2022, an estimated $58K.
  • Point72 Hong Kong first reported a position in Sana Biotechnology in Q4 2021 and held it in 2 quarters.
  • Point72 Hong Kong's Sana Biotechnology position peaked at $58K in Q3 2022.
  • 119 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.